SHARE-BASED COMPENSATION (SARS Activity) (Details) - Stock Appreciation Rights (SARs) [Member] - USD ($)	12 Months Ended
	Feb. 03, 2024	Jan. 28, 2023	Jan. 29, 2022
Number of Underlying Shares Outstanding [Roll Forward]
Number of Underlying Shares, Outstanding (in shares)	25,600	190,589
Number of Underlying Shares, Granted (in shares)	0
Number of Underlying Shares, Exercised (in shares)	(141,289)
Number of Underlying Shares, Forfeited or expired (in shares)	(23,700)
Weighted-Average Exercise Price [Roll Forward]
Weighted-Average Exercise Price, Outstanding (in dollars per share)	$ 29.29	$ 29.43
Weighted-Average Grant Date Fair Value, Granted (in dollars per share)	0
Weighted-Average Exercise Price, Exercised (in dollars per share)	26.73
Weighted-Average Exercise Price, Forfeited or exercised (in dollars per share)	$ 45.69
Aggregate Intrinsic Value, Outstanding	$ 2,053
Weighted-Average Remaining Contractual Life, Outstanding	8 months 12 days
Number of Underlying Shares, Stock appreciation rights exercisable (in shares)	25,600
Weighted-Average Exercise Price, Stock appreciation rights exercisable (in dollars per share)	$ 29.29
Aggregate Intrinsic Value, Stock appreciation rights exercisable	$ 2,053
Weighted- Average Remaining Contractual Life, Stock appreciation rights exercisable	8 months 12 days
Grant date fair value of award other than options vested during period	$ 1,409,000	$ 0	$ 1,069,000